Cargando…
KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes
OBJECTIVE: Increasing plasma levels and activity of dipeptidyl peptidase-4 (DPP4 or CD26) are associated with rapid progression of metabolic syndrome to overt type 2 diabetes mellitus (T2DM). While DPP4 inhibitors are increasingly used as anti-hyperglycemic agents, the reason for the increase in pla...
Autores principales: | Nargis, Titli, Kumar, Krishna, Ghosh, Amrit Raj, Sharma, Amit, Rudra, Dipayan, Sen, Debrup, Chakrabarti, Saikat, Mukhopadhyay, Satinath, Ganguly, Dipyaman, Chakrabarti, Partha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681279/ https://www.ncbi.nlm.nih.gov/pubmed/29107298 http://dx.doi.org/10.1016/j.molmet.2017.09.004 |
Ejemplares similares
-
An Observational Study showing Dipeptidyl Peptidase-4 (DPP-4) Activity and Gene Expression Variation in Chronic Liver Disease (CLD) Patients from a Tertiary Care Hospital of Eastern India
por: Barkondaj, Bikramjit, et al.
Publicado: (2022) -
Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients
por: Sarkar, Jit, et al.
Publicado: (2019) -
Impaired compensatory hyperinsulinemia among nonobese type 2 diabetes patients: a cross-sectional study
por: Sarkar, Jit, et al.
Publicado: (2019) -
Neck height ratio is an important predictor of metabolic syndrome among Asian Indians
por: Selvan, Chitra, et al.
Publicado: (2016) -
DBC1, p300, HDAC3, and Siah1 coordinately regulate ELL stability and function for expression of its target genes
por: Basu, Subham, et al.
Publicado: (2020)